Mechanistically, MALAT1 recruited the transcription factor Sp1 to the promoter of LTBP3, thereby resulting in elevated level of LTBP3 transcription and TGF-β1 secretion, which plays a role in the suppression of bone formation in MM bone lesions [29]. The gene discussed is MALAT1; the disease is Miyoshi myopathy.